These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3896600)

  • 1. Remission of Goodpasture's syndrome after withdrawal of an unusual toxic.
    Bernis P; Hamels J; Quoidbach A; Mahieu P; Bouvy P
    Clin Nephrol; 1985 Jun; 23(6):312-7. PubMed ID: 3896600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Goodpasture's syndrome--local and diffuse deposition of antibody in glomerular basement membrane. Case report.
    Tomaszewski MM; Hassell LH; Moore J; Antonovych TT
    Clin Nephrol; 1983 Jul; 20(1):44-8. PubMed ID: 6224622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of kidney-bound antibodies in Goodpasture's syndrome.
    Saxena R; Bygren P; Butkowski R; Wieslander J
    Clin Exp Immunol; 1989 Oct; 78(1):31-6. PubMed ID: 2805421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of both anti-GBM and immune complex mediated pathogenesis in the initial phase of Goodpasture's syndrome.
    Pasternack A; Törnroth T; Linder E
    Clin Nephrol; 1978 Feb; 9(2):77-85. PubMed ID: 147761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Goodpasture's syndrome. A new case].
    Nolen P; Touchard G; d'Eyzac AT; Patte F; Patte D; Morichau-Beauchant G
    Poumon Coeur; 1976; 32(6):325-9. PubMed ID: 794860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of Goodpasture's syndrome with IgA antibasement membrane antibody].
    Nakano H; Suzuki A; Tojima H; Watanabe A; Mizuguchi K; Shinozaki T; Kamei K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr; 28(4):634-8. PubMed ID: 2214406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to human glomerular basement membrane: modified methodology for detection in human serum.
    Buffaloe GW; Evans JE; McIntosh RM; Glassock RJ; Tavel TB; Terman DS
    Clin Exp Immunol; 1980 Jan; 39(1):136-40. PubMed ID: 7389188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-GBM disease: predictive value of clinical, histological and serological data.
    Herody M; Bobrie G; Gouarin C; Grünfeld JP; Noel LH
    Clin Nephrol; 1993 Nov; 40(5):249-55. PubMed ID: 8281713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme immunoassay of anti-glomerular basement membrane antibodies.
    Fish AJ; Kleppel M; Jeraj K; Michael AF
    J Lab Clin Med; 1985 Jun; 105(6):700-5. PubMed ID: 2987380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical spectrum of acute glomerulonephritis and lung haemorrhage (Goodpasture's syndrome).
    Holdsworth S; Boyce N; Thomson NM; Atkins RC
    Q J Med; 1985 Apr; 55(216):75-86. PubMed ID: 4011844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-basement membrane antibodies in immunologic renal disease.
    Wilson CB; Holdsworth SR; Neale TJ
    Aust N Z J Med; 1981; 11(Suppl 1):94-100. PubMed ID: 7020672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Goodpasture's syndrome. Observations on a case].
    Italiano F; Carelli E; Prato G; Bonardi R; Triolo R
    Minerva Med; 1978 May; 69(25):1749-59. PubMed ID: 351462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goodpasture's syndrome with asymptomatic renal involvement. Disappearance of antiglomerular basement membrane antibodies deposits after treatment.
    Lamriben L; Kourilsky O; Mougenot B; Ronco P; Sraer JD
    Nephrol Dial Transplant; 1993; 8(11):1267-9. PubMed ID: 8302468
    [No Abstract]   [Full Text] [Related]  

  • 15. The spectrum of renal diseases associated with anti-basement membrane antibodies.
    Senekjian HO; Knight TF; Weinman EJ
    Arch Intern Med; 1980 Jan; 140(1):79-81. PubMed ID: 6986125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of circulating anti-glomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange.
    Hind CR; Bowman C; Winearls CG; Lockwood CM
    Clin Nephrol; 1984 Apr; 21(4):244-6. PubMed ID: 6733989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases.
    Merkel F; Pullig O; Marx M; Netzer KO; Weber M
    Nephrol Dial Transplant; 1994; 9(4):372-6. PubMed ID: 8084449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome.
    Hajime N; Michiko A; Atsunori K; Tatsuo K; Yuko N; Naoki O; Katsuhiko S
    Ther Apher Dial; 2009 Aug; 13(4):373-7. PubMed ID: 19695077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent Goodpasture's syndrome.
    Dahlberg PJ; Kurtz SB; Donadio JV; Holley KE; Velosa JA; Williams DE; Wilson CB
    Mayo Clin Proc; 1978 Aug; 53(8):533-7. PubMed ID: 682682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Goodpasture's syndrome and nephrocalcinosis].
    Koall W; Mampel E; Schneider W; Ditscherlein G
    Z Gesamte Inn Med; 1977 Jul; 32(13):313-9. PubMed ID: 930188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.